NeuroImage
May 1, 2020
Matthew I Banks, Bryan M Krause, Christopher M Endemann et al.
78 citations
Disruption of cortical connectivity likely contributes to loss of consciousness during sleep and general anesthesia, but the degree of overlap in mechanisms is unclear. Using intracranial recordings from five adult neurosurgical patients, alpha-band connectivity (measured by weighted phase lag index) was compared across natural sleep stages and propofol anesthesia. In wake states, alpha-band connectivity within the temporal lobe was dominant, a pattern largely unchanged in light sleep (N1, REM) and sedated states. Transitions into states of reduced consciousness (deep sleep N2/N3 and anesthesia-induced unresponsiveness) showed dramatic shifts, with dominant connections moving to prefrontal cortex. The findings suggest common mechanisms of loss of consciousness in sleep and anesthesia.
Translational psychiatry
September 12, 2024
Christopher R Nicholas, Matthew I Banks, Richard C Lennertz et al.
10 citations
Psilocybin, a serotonergic psychedelic, can relieve symptoms in several psychiatric disorders and improve well-being, but it was unclear whether these benefits arise during the acute experience or depend on later memory of it. In 8 healthy participants, psilocybin (25 mg) was co-administered with the amnestic benzodiazepine midazolam at a dose that allowed a conscious psychedelic experience while partially impairing memory for it. Higher midazolam doses and greater memory impairment tended to associate with lower salience, insight, and well-being from psilocybin. These results suggest memory plays a role in therapeutically relevant behavioral effects of psilocybin.
Psychedelic medicine (New Rochelle, N.Y.)
September 1, 2024
Zarmeen Zahid, Ziyad W Sultan, Bryan M Krause et al.
5 citations
In mice, the serotonergic psychedelic DOI, but not ketamine, enhanced neural plasticity and metaplasticity in the hippocampus 24 hours after a single dose. Brain slices from DOI-treated animals showed stronger synaptic responses and short-term potentiation compared to saline-treated controls, with evidence that these effects involve a presynaptic mechanism. Ketamine did not produce similar changes. These findings suggest that the therapeutic benefits of serotonergic psychedelics may be supported by a window of heightened neural plasticity, whereas ketamine's effects may rely on different mechanisms.
AJNR. American journal of neuroradiology
June 3, 2025
Paloma C Frautschi, Ajay P Singh, Nicholas A Stowe et al.
2 citations
Psilocybin treatment in male mice led to structural connectivity differences in the frontal association cortex after 72 hours and microstructural changes in the primary visual cortex after 24 hours, as well as in the striatum and hippocampus after 72 hours, including increased mean diffusivity and decreased neurite density. These findings suggest that diffusion microstructure imaging can detect and characterize brain changes induced by psilocybin, offering a potential method to monitor treatment response and identify clinical endpoints for patients with major depressive disorder.